Edgar T Overton, MD
University of Alabama at Birmingham
3
2
3
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John Flaherty, PharmD
Gilead Sciences
Shared therapeutic areas:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
Richard J Jurevic, DDS, PhD
Case CRS
Shared therapeutic areas:
Worked with same sponsors:
Raphael Landovitz, MD
University of California, Los Angeles
Shared therapeutic areas:
Rana Traboulsi, MD
Case CRS
Shared therapeutic areas:
Worked with same sponsors:
Michael C Sneller, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
Pablo Tebas, M.D.
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
Kristine Erlandson, MD
University of Colorado, Denver
Shared therapeutic areas:
Worked with same sponsors:
Steven Deeks, MD
University of California, San Francisco
Shared therapeutic areas:
Worked with same sponsors:
Marius Trøseid, MD, PhD
Oslo University Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
All 3 trials loaded